Synovus Financial’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-8,501
Closed -$216K 898
2022
Q3
$216K Sell
8,501
-246
-3% -$8.63K ﹤0.01% 778
2022
Q2
$288K Sell
8,747
-47
-0.5% -$2K ﹤0.01% 731
2022
Q1
$639K Sell
8,794
-9,435
-52% -$680K 0.01% 549
2021
Q4
$1.68M Sell
18,229
-3,740
-17% -$447K 0.02% 356
2021
Q3
$2.78M Buy
21,969
+1,356
+7% +$197K 0.03% 257
2021
Q2
$3.41M Buy
20,613
+52
+0.3% +$8.43K 0.03% 230
2021
Q1
$3.74M Buy
20,561
+854
+4% +$198K 0.04% 200
2020
Q4
$3.94M Buy
19,707
+774
+4% +$157K 0.05% 194
2020
Q3
$4.15M Sell
18,933
-697
-4% -$148K 0.06% 168
2020
Q2
$3.75M Sell
19,630
-7,411
-27% -$1.3M 0.05% 162
2020
Q1
$4.19M Sell
27,041
-259
-0.9% -$30.1K 0.06% 168
2019
Q4
$2.29M Buy
27,300
+861
+3% +$65.5K 0.03% 225
2019
Q3
$1.79M Buy
26,439
+15,725
+147% +$1.03M 0.03% 240
2019
Q2
$711K Buy
10,714
+9,936
+1,277% +$579K 0.01% 395
2019
Q1
$43K Buy
778
+434
+126% +$26.5K ﹤0.01% 853
2018
Q4
$18K Buy
344
+127
+59% +$7.77K ﹤0.01% 1001
2018
Q3
$19K Buy
217
+152
+234% +$10.8K ﹤0.01% 1034
2018
Q2
$4K Buy
+65
New +$3.17K ﹤0.01% 1170

Other funds holding TDOC

Synovus Financial's TDOC Position: Q4 2022 in Review

Synovus Financial sold out of Teladoc Health (TDOC) in Q4 2022, closing a stake of 8,501 shares — an estimated $216K sold.

Synovus Financial first reported a position in TDOC in Q2 2018 and held it in 18 quarters. The position peaked at $4.19M in Q1 2020. 443 funds tracked by Wall St. Rank hold TDOC as of Q4 2022.

  • Synovus Financial reported no remaining Teladoc Health position as of Q4 2022 after selling out during the quarter.
  • Synovus Financial sold 8,501 Teladoc Health shares in Q4 2022, an estimated $216K.
  • Synovus Financial first reported a position in Teladoc Health in Q2 2018 and held it in 18 quarters.
  • Synovus Financial's Teladoc Health position peaked at $4.19M in Q1 2020.
  • 443 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2022.

Based on Synovus Financial's 13F filing for Q4 2022, filed 6 Feb 2023.